Evotec Sustainability Profile
Evotec SE, a leading global biotechnology company headquartered in Germany, is renowned for its innovative drug discovery and development solutions. Founded in 1993, Evotec has established a strong presence in Europe, North America, and Asia, focusing on areas such as central nervous system disorders, metabolic diseases, and oncology. The company offers a unique platform that integrates cutting-edge technologies and extensive expertise, enabling efficient and effective drug development processes. Notable achievements include strategic partnerships with major pharmaceutical firms, positioning Evotec as a key player in the biopharmaceutical industry. With a commitment to advancing healthcare, Evotec continues to drive progress in the development of novel therapeutics, making significant contributions to the global fight against disease.
DitchCarbon Score
How does Evotec's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Evotec's score of 92 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Evotec's reported carbon emissions
In 2024, Evotec SE reported total greenhouse gas emissions of approximately 200,930,000 kg CO2e, with Scope 1 emissions at about 13,756,000 kg CO2e, Scope 2 emissions (market-based) at approximately 6,913,000 kg CO2e, and a significant Scope 3 total of about 180,262,000 kg CO2e. This represents a decrease from 2023, where total emissions were about 300,670,000 kg CO2e, with Scope 1 at approximately 15,937,000 kg CO2e, Scope 2 (market-based) at about 11,672,000 kg CO2e, and Scope 3 at around 273,060,000 kg CO2e. Evotec has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 GHG emissions by 50.4% by 2032 from a 2021 base year. Additionally, they plan to achieve a 95% reduction in these emissions by 2045. For Scope 3 emissions, the company targets a 72% reduction from purchased goods and services and capital goods by 2032. Furthermore, Evotec is committed to sourcing 100% renewable electricity by 2026 and ensuring that 80% of its suppliers by emissions have science-based targets by 2027. These targets align with the Science Based Targets initiative (SBTi) and reflect Evotec's commitment to achieving net-zero emissions across its value chain by 2045. The company is actively working towards these goals, demonstrating a strong commitment to sustainability within the pharmaceutical and biotechnology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 28,000 | 00,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 32,701,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 |
| Scope 3 | 1,464,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Evotec's Industry?
How Carbon Intensive is Evotec's Location?
Evotec's Scope 3 Categories Breakdown
Evotec's Scope 3 emissions, which decreased by 34% last year and increased significantly since 2019, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 70% of Scope 3 emissions.
Top Scope 3 Categories
Evotec's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Evotec has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Frequently Asked Questions
Common questions about Evotec's sustainability data and climate commitments